Echocardiography in Nursing Home
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorNantes University Hospital
About this trial
The study seeks to explore the implementation characteristics (acceptability, appropriateness, feasibility, adoption, fidelity, penetration, implementation cost and sustainability) of systematic echocardiography in nursing homes and its impact on rates of heart failure flare-up and unscheduled hospitalization at 12 months among included nursing homes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
no accessible to echocardiography
closed unit (severe Alzheimer disease…)
recent contagious disease such Covid (<15 days)
no consent to participate
Trial design
Design model
Parallel
Treatments tested in this trial
Implementation of echocardiography in nursing homes
Diagnostic testAn ultrasound will be carried out in the EHPAD, the result of which will be interpreted by a cardiologist then sent to the establishment and the attending physician with instructions to follow.
Treatment groups
1,050 Participants
are divided into 2 treatment groupsGroup A: Echocardiographic screening armExperimental treatment 1 intervention
Group B: Usual careNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Count of resident presenting a heart failure decompensation
Number of residents with heart failure flare (worsening of at least 1 NYHA class) or unplanned hospitalization for heart failure
Time frame
12 monthsSecondary outcomes
1
Presence of a clinically significative change in medical management and care in the month following ultrasound
A binary outcome will be constructed, based on the following algorithm: clinically significative change set to "yes" if a change in ongoing drug prescription is observed, and/or a cardiologist visit is planned, and/or a geriatrist visit is planned, and/or an hospitalization for clinical work-up is set, and/or a resume of the ultrasound is sent to the GP. Otherwise (all components set to "absent"), this outcome will be set to "None".
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Nantes University Hospital
Lead sponsor
Directorate of Health Care Supply
Collaborator
Source ClinicalTrials.gov